COVID-19: Responding to the Pandemic

As an organization dedicated to promoting the health and well-being of the most vulnerable people worldwide, MSH is deeply concerned about how COVID-19 is threatening so many of the communities we support. National health systems are overwhelmed and pharmaceutical supply chains are threatened. The impacts of the pandemic are keenly felt among populations with pre-existing conditions, from non-communicable diseases to TB, HIV, malaria, and more.  

This is a stark reminder of the need for robust health systems, the importance of investing in them, and the challenges many countries already face in providing reliable access to effective care. MSH’s work includes preventing the spread of infectious disease, including COVID-19.

What we are doing  

MSH is undertaking specific COVID-19 preparedness, response, and recovery interventions in 20 countries, sharing our expertise and resources in infection prevention and control, emergency preparedness planning, advocacy and stakeholder coordination, surveillance, leadership development, and overall health systems strengthening with a wide range of institutions and agencies responding to the pandemic. Learn More

The USAID Medicines, Technologies and Pharmaceutical Services Program, led by MSH, is on the frontlines, supporting high-risk countries. The program’s COVID-19 approach includes two important strategies: implementing end-to-end infection prevention and control (IPC) measures in health facilities, including precautions and procedures; and strengthening commodity management to ensure access to a steady supply of medicines, masks, and hygiene products. Read more  

Strengthening health systems to contain outbreaks

MSH works to address critical gaps in health system infrastructures that hinder the prevention and early detection of and response to infectious disease outbreaks. We work to ensure quality service delivery, improve infection prevention and control measures in health facilities, enhance community engagement, build a skilled health workforce, support robust information systems, and contribute to effective pharmaceutical and supply chain management.  Learn more 

Advocating for global health security

MSH works on its own and in collaboration with global non-profits, academic organizations, and the private sector to educate policymakers on the importance of funding global health security, and COVID-19 response in particular. On Capitol Hill, MSH has engaged new advocates through our Breakfast Series on Health Security, and we supported legislation designed to increase health security efforts for the US and other countries through the Global Health Security Act of 2019 and the Frontline Healthcare Workers Resolution. We called for adequate funding for COVID-19 through emergency supplemental funding requests, as well as helped members of Congress communicate about the virus to their constituents. MSH staff frequently communicate to the media about COVID-19 and the importance of health systems strengthening to prevent and contain infectious disease. Outlets for recent contributions and appearances include The Guardian, BBC Radio and World News Live, France 24, The Wall Street Journal, Devex, Global Health NOW, and Canada’s Jerry Agar show. Learn more